Company
Oncorus, Inc. (0001671818)
Standardized SEC financial data for Oncorus, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001671818 · Pharmaceutical Preparations.
Return on equity
-127.9%
ROIC
-81.4%
Free cash flow
-$81.6M
Debt / equity
0.65×
Current ratio
1.74×
EPS (diluted)
$-2.99
Income statement
| USD | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
| R&D expense | $24.0M | $27.2M | $44.7M | $54.7M |
| SG&A expense | $7.1M | $10.0M | $20.1M | $21.8M |
Balance sheet
| USD | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Cash & equivalents | $20.1M | $45.3M | $133.2M | $104.2M | $29.1M |
| Total current assets | — | $45.9M |
Cash flow
| USD | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
| Operating cash flow | -$27.2M | -$36.8M | -$49.8M | -$61.7M |
| Capital expenditures | $977K | $1.1M | $9.5M | $19.9M |
Get 0001671818 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001671818/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001671818/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"